Active BE 0788.182.012Private limited company

Biomedical Science & Sports

Putstraat(Hak) 16 ·3300 Tienen, Belgium· 4 yrs active

Sector: Computer consultancy and computer facilities management (62200)

Conclusion Checked

Biomedical Science & Sports has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-5k) and a net result of €-11k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 12% of 181 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.9% (low).

Based on the State Gazette, CBE and 4 annual accounts.

Key figures

Equity	€-5k
Net result	€-11k
Better than sector	12%
Active	4 yrs

Financial profile 5 of 5 axes measured · computed by Checked

61 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 32

Profitability 100

Solvency 46

Growth 32

Stability 94

Bankruptcy probability (12 mo) Checked model v1 · free

0.9% Low

0%0,5%1,5%4%10%≥25%

How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 2 signals

More than 3 years active

Founded in 2022, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags0 events

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Checked score FY 2025 · computed

32 / 100 Weak

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Financial overview4 NBB filings

Annual accounts filed on 05-08-2026 with the NBB · fiscal year 2025 · abbreviated schema

Operating resultNet result

Sector comparison

Fiscal year 2025 · NACE 62, Computer programming, consultancy and related activities · compared within the same schema type (abbreviated schema)

Metric	This company	Sector median	Position in the sector
Solvency	-24.9%	38.3%	better than 12% of 181 sector peers
Net result	€-11k	€27k	better than 24% of 181 sector peers
Equity	€-5k	€103k	better than 14% of 181 sector peers
Gross operating margin	€-2k	€86k	better than 14% of 181 sector peers
Staff costs	€400	€350k	higher than 5% of 86 sector peers

EBITDA

€-5k

- 22-25

Net profit

€-11k

-399.9% 22-25

Cash flow

€-8k

- 22-25

Total assets

€19k

-76.3% 22-25

Equity

€-5k

- 22-25

Working capital

€159

-99.1% 22-25

Staff costs

€400

- 22-25

Income taxes

€625

-54.3% 22-25

Debt

€23k

-67.8% 22-25

Debt ≤ 1y

€2k

-78.3% 22-25

Debt > 1y

€22k

-66.4% 22-25

Current ratio

1.09

-65.0% 22-25

Quick ratio

1.09

-65.0% 22-25

Solvency

-24.9%

- 22-25

Debt / equity

-5.01

- 22-25

ROE

235.6%

- 22-25

ROA

-58.8%

-2008.0% 22-25

Interest coverage

-1.80

- 22-25

Figures by fiscal year and ratios

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	abbreviated schema
Revenue	-
EBITDA	€-5k
Net profit	€-11k
Cash flow	€-8k
Staff costs	€400
Income taxes	€625
Dividends	-
Total assets	€19k
Equity	€-5k
Debt	€23k
of which ≤ 1y	€2k
of which > 1y	€22k
Working capital	€159
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	1.09
Quick ratio	1.09
Working capital ratio	0.9%
Solvency	-24.9%
Debt / equity	-5.01
Long-term debt ratio	-4.62
Interest coverage	-1.80
Gross margin	-
Net margin	-
ROA	-58.8%
ROE	235.6%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →

Balance-sheet composition 2025

Assets

Fixed assets €17k · 89.5% Current assets €2k · 10.5%

Full annual accounts (22 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€19k
Fixed assets	21/28	€17k
Tangible fixed assets	22/27	€17k
Current assets	29/58	€2k
Amounts receivable within one year	40/41	€1k
Cash & bank	54/58	€566
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€19k
Equity	10/15	€-5k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€-8k
Amounts payable	17/49	€23k
Amounts payable after one year	17	€22k
Amounts payable within one year	42/48	€2k
Trade debts payable within one year	44	€859
Income statement
Gross operating margin	9900	€-2k
Operating result	9901	€-8k
Financial income	75	€371
Financial charges	65	€3k
Result before taxes	9903	€-10k
Income taxes	67/77	€625
Net result for the period	9904	€-11k
Result to be appropriated	9905	€-11k

Legal Structure

NACE primary	Computer consultancy and computer facilities management(62200)
Legal form	Private limited company(610)
Incorporation	04-07-2022
Status	Active
Postal code	3300

Establishment units 1 location

Biomedical Science & Sports

Putstraat(Hak) 16, 3300 TienenIT consultancy

since 20222.334.236.110

Real-estate footprint Source: CBE × cadastre

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
24035B0113/00N000	Flanders	2,010 m²	1 · 318 m²	17.2 m · 2 fl.

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 4 events

All 7Financial 3Filings 4

Next filing, fiscal year 2026, expected by 31-07-2027

2026

05-08

NBB filing Annual accounts filed

fiscal year 2025 · abbreviated schema · 5 days late

2025

31-12

Financial Weakest financial yearnet €-11k

Net result drops to €-11k, the lowest in the series.

12-08

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 12 days late

2024

31-12

Financial Liquidity doublescurrent ratio 3.11

Current ratio from 1.50 to 3.11; short-term debt falls from €13k to €8k.

15-07

NBB filing Annual accounts filed

fiscal year 2023 · micro schema

2023

31-12

Financial Highest result since 2022net €3k ▲14.6%

Net result €3k, the highest in the series.

02-10

NBB filing Annual accounts filed

fiscal year 2022 · micro schema · 63 days late

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Belgian State Gazette reading coverage 0 of 1 acts read

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Credit advice verdict per customer and amount

Company registry (CBE) Crossroads Bank

Activities

IT consultancy62020Computer consultancy and computer facilities management62200

Names & trade names

Legal nameNL

Biomedical Science & Sports

Similar companies Comparable size · 17,819 of 29,953 companies in this sector with filed accounts

TANA-TECH BE 0750.650.138 · Gembloux

FUTURE BUSINESS ARCHITECTS BE 0788.190.821 · Glabbeek

BI CONSULTING BE 1014.282.577 · Enghien

CrossCode BE 0800.715.006 · Lennik

JV-IT BE 0762.685.660 · Jurbise